Artiva Biotherapeutics (ARTV) Institutional Ownership

During the previous two years, 20 institutional investors and hedge funds held shares of Artiva Biotherapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($152.23M), Franklin Resources Inc. ($7.44M), Samsara BioCapital LLC ($4.51M), Geode Capital Management LLC ($3.18M), Wellington Management Group LLP ($2.91M), RTW Investments LP ($2.30M), and State Street Corp ($1.34M).Learn more on ARTV's institutional investors.

Of the 18 institutional investors that purchased Artiva Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($9.85M), Franklin Resources Inc. ($520.30K), Geode Capital Management LLC ($315.76K), Samsara BioCapital LLC ($291.67K), Wellington Management Group LLP ($194.11K), RTW Investments LP ($148.84K), and State Street Corp ($86.56K).

Institutional investors have bought a total of 11,662,341 shares in the last 24 months. This purchase volume represents approximately $179.58M in transactions.

The following institutional investors have sold Artiva Biotherapeutics stock in the last 24 months: Bank of America Corp DE ($7.00K), and Rhumbline Advisers ($1.95K).

Institutional investors have sold a total of 8,951 shares in the last 24 months. This volume of shares sold represents approximately $90.23K in transactions.